No open-market selling at Harvard Apparatus Regenerative Technology, Inc. in the past year, which is unusual. Instead one the people running the company bought about $400,000 worth of HRGN.
Biggest single buyer: He Junli, CEO, with roughly $380,000. C-suite participation is part of the picture here.
Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | He Junli | CEO | Buy | 361,905 | $1.05 | $380K | SEC |
| Sep 25, 2026 | He Junli | CEO | Buy | 6,725 | $2.15 | $14K | SEC |
| Dec 1, 2025 | He Junli | CEO | Buy | 3,000 | $1.70 | $5K | SEC |
| Oct 1, 2025 | He Junli | CEO | Buy | 300 | $1.98 | $594 | SEC |
| Sep 24, 2025 | He Junli | CEO | Buy | 11,225 | $1.85 | $21K | SEC |
| Sep 2, 2025 | He Junli | CEO | Buy | 4,050 | $1.72 | $7K | SEC |
| Jan 2, 2025 | He Junli | CEO | Buy | 2,299 | $2.87 | $7K | SEC |
| Sep 12, 2024 | He Junli | CEO | Buy | 5,101 | $3.37 | $17K | SEC |
| Jul 2, 2024 | He Junli | CEO | Buy | 1,600 | $2.80 | $4K | SEC |
| Jan 3, 2024 | He Junli | CEO | Buy | 2,700 | $4.76 | $13K | SEC |
| Dec 18, 2023 | He Junli | CEO | Buy | 900 | $4.92 | $4K | SEC |
| Dec 11, 2023 | He Junli | CEO | Buy | 1,500 | $5.07 | $8K | SEC |
| Sep 18, 2023 | He Junli | CEO | Buy | 1,500 | $5.43 | $8K | SEC |
| Sep 5, 2023 | He Junli | CEO | Buy | 3,400 | $4.69 | $16K | SEC |
| Aug 28, 2023 | He Junli | CEO | Buy | 8,000 | $4.32 | $35K | SEC |
In the last 12 months Harvard Apparatus Regenerative Technology, Inc. insiders made open-market purchases worth about $400,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in HRGN was filed on 2026-09-25.
No congressional trades in HRGN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).